Modelling and simulation in the development of medicines

Tuesday 15 Nov 2016 @ 10:20
EU News

Watch live broadcast of expert discussion at EMA

A workshop on the use of innovative modelling and simulation approaches during the development and regulatory assessment of medicines will take place at the European Medicines Agency (EMA) on 21 November 2016.

You can follow a live broadcast of the workshop by clicking on the 'multimedia' tab on the event page.

The workshop is organised as part of a public consultation on a new EMA guideline on physiologically-based pharmacokinetic (PBPK) modelling and simulation that was launched in July 2016. Comments on the guidance are invited until 31 January 2017.

The aim of the workshop is to bring together regulatory agencies, pharmaceutical industry, academia, patient representatives and software developers to discuss the role of PBPK models in the development and regulatory review of medicines. The workshop also aims to explain the main elements of the new guidance, gather the views of stakeholders and provide details on qualification procedures and evaluation of such models.

PBPK modelling is increasingly used by medicine developers, e.g. to predict the interaction between medicines in the body or to help define the initial dose of a medicine in pediatric and first-in-human trials.

As new scientific data are generated and confidence in PBPK modelling increases, these models are expected to be used in other aspects of the development of medicines in the near future.

EMA’s draft guideline clarifies how these models can support decision making in the context of a marketing authorisation application. It provides detailed advice on the data that should be included in a PBPK modelling report of an application dossier. The document also emphasises the need for PBPK platforms to be ‘qualified’ and evaluated for a specific use if they are to support regulatory decisions.

Latest News from
EU News

EU increases humanitarian aid to Gaza by €25 million

07/11/2023 13:25:00

As part of the EU's continued support to people in Gaza, the Commission will provide a further €25 million in humanitarian aid. This quadruples EU humanitarian assistance to over €100 million for Gaza this year.

President von der Leyen marks the EU's commitment to the Partnership for Global Infrastructure and Investment (PGII) during the event hosted at the G20 in New Delhi

12/09/2023 15:25:00

President von der Leyen recently (09 September 2023) spoke at the G20 event on PGII hosted by Prime Minister Modi and President Biden.

Summer 2023 Economic Forecast: Easing growth momentum amid declining inflation and robust labour market

12/09/2023 13:25:00

The European Commission yesterday presented the Summer 2023 Economic Forecast

Climate change: Deal on a more ambitious Emissions Trading System (ETS)

20/12/2022 10:33:00

On Saturday night, MEPs and EU governments agreed to reform the Emissions Trading System to further reduce industrial emissions and invest more in climate friendly technologies.

EU and Ukraine sign €100 million for the rehabilitation of war-damaged schools *

20/12/2022 09:25:00

Exactly three months after President von der Leyen's announcement in her 2022 State of the Union Address, the European Commission and the Government of Ukraine have signed a €100 million support package for the reconstruction and rehabilitation of schooling facilities damaged in Russia's full-scale war of aggression against Ukraine.

NextGenerationEU: European Commission endorses positive preliminary assessment of Portugal's second request for €1.8 billion disbursement under the Recovery and Resilience Facility

19/12/2022 16:33:00

The European Commission recently (16 December 2022) endorsed a positive preliminary assessment of Portugal's payment request for €1.8 billion of grants and loans under the Recovery and Resilience Facility (RRF), the key instrument at the heart of NextGenerationEU.

WIREDGOV